Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-007882)

Filing Details

Accession Number:: 0001209191-19-007882
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-06 19:23:07
Reporting Period:: 2019-02-04

Accepted Time:: 2019-02-06 19:23:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1305253	Eiger Biopharmaceuticals Inc.	EIGR	Biological Products, (No Disgnostic Substances) (2836)	361004130

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1670137	A David Cory	C/O Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-04	227	$14.13	58,678	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	30,123	Indirect	See footnote

Footnotes

Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.